Virax Biolabs Group Ltd
NASDAQ:VRAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Virax Biolabs Group Ltd
NASDAQ:VRAX
|
UK |
|
Inficon Holding AG
SIX:IFCN
|
CH |
|
I
|
Ibersol SGPS SA
ELI:IBS
|
PT |
|
Moleculin Biotech Inc
NASDAQ:MBRX
|
US |
|
J
|
JHT Design Co Ltd
SSE:603061
|
CN |
|
Wendel SE
PAR:MF
|
FR |
|
Iss A/S
OTC:ISFFF
|
DK |
|
D'Ieteren Group NV
F:DJDA
|
BE |
|
Zenith Capital Corp
OTC:ZHCLF
|
CA |
|
B
|
Bertrandt AG
XBER:BDT
|
DE |
|
Swire Pacific Ltd
HKEX:19
|
HK |
|
Clean Seed Capital Group Ltd
XTSX:CSX
|
CA |
|
Daikin Industries Ltd
TSE:6367
|
JP |
|
Rekor Systems Inc
F:38E
|
US |
Bankruptcy Probability
Virax Biolabs Group Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virax Biolabs Group Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
V
|
Virax Biolabs Group Ltd
NASDAQ:VRAX
|
3.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
96.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
55.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
54.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
52.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
60.2B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
51.1B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
52.4B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virax Biolabs Group Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virax Biolabs Group Ltd has total debt of 471.6k USD. This includes both short-term (195.6k USD) and long-term (276k USD) debt.
You can find a full breakdown on its Balance Sheet.
